You are here

Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Gainesville, Florida, 32608 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hepatitis C, Hepatic Insufficiency
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-70 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Men and women of non-childbearing potential.

- Hepatic impairment subjects: Child-Pugh class A, B, or C according to the C-P
classification based on history, physical examination, and laboratory test results.

- Healthy volunteers: healthy as determined by the investigator.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- History of alcoholism within 1 year.

- Hepatic impairment subjects: evidence of unstable clinically significant disease other
than impaired hepatic function.

- Healthy volunteers: positive serologic findings for hepatitis B surface antigen
(HBsAg) and/or hepatitis C virus (HCV) antibodies.

NCT00314054
Pfizer
Completed
Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now